药明康德又从药明合联身上“薅钱”了。10月10日,无锡药明康德发布公告称,已通过大宗交易方式,出售了其间接控股子公司所持有的药明合联3030万股股票,约占药明合联当前总股本的2.47%,套现约23.46亿港元。这已经是药明康德近一年内第四次大规模减持药明合联,累计套现近70亿港元。令人费解的是,眼下药明康德业绩复苏强劲,药明合联业绩也表现不错。那么,药明康德为何还要多次减持套现?近一年减持套现近...
Source Link药明康德又从药明合联身上“薅钱”了。10月10日,无锡药明康德发布公告称,已通过大宗交易方式,出售了其间接控股子公司所持有的药明合联3030万股股票,约占药明合联当前总股本的2.47%,套现约23.46亿港元。这已经是药明康德近一年内第四次大规模减持药明合联,累计套现近70亿港元。令人费解的是,眼下药明康德业绩复苏强劲,药明合联业绩也表现不错。那么,药明康德为何还要多次减持套现?近一年减持套现近...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.